Ultra™ Duramune® DAP is effective for vaccination against canine distemper, infectious canine hepatitis, canine adenovirus type 2 and canine parvovirus.
Shipping : Perishable
ULTRA Duramune DAP + 4L, by Boehringer Ingelheim Vetmedica, Inc., is the first and only premium 1/2 mL vaccine line for dogs of all sizes. ULTRA Duramune offers a more comfortable injection with 50% less volume and has the same high level of efficacy and potency that has made Duramune a trusted name for 30 years. ULTRA Duramune DAP is a Modified Live Vaccine for Canine distemper, Adenovirus 2, Canine Parvovirus 2b, and Killed Canine Leptos.
Ultra™ Duramune® DAP is effective for vaccination against canine distemper, infectious canine hepatitis, canine adenovirus type 2 and canine parvovirus.
Ultra™ Duramune® vaccines reduce vaccine volume to ½. This minimal injection volume reduces discomfort for the dog. In addition, these vaccinations are highly purified in order to minimize reactions associated with unwanted proteins and debris.
This canine dap vaccine is for dogs 6 weeks and older. Modified live virus.
ULTRA™ DURAMUNE™ DAP + 4L
Canine Distemper-Adenovirus Type 2-Parvovirus Vaccine
Modified Live Virus
Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract
For use in animals only
This product has been shown to be effective for vaccination of healthy dogs 6 weeks of age or older against canine distemper, infectious canine hepatitis, canine adenovirus type 2, canine parvovirus (CPV), Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae and Leptospira pomona. The duration of immunity for this product has not been determined. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.
This product contains a CPV 2b strain which has been demonstrated effective against disease caused by CPV 2c in puppies with CPV maternal antibody.
Directions for use
• General directions: Aseptically rehydrate ULTRA Duramune DAP with low volume diluent supplied. Administer one 0.5 mL dose subcutaneously.
• Primary vaccination: The presence of maternal antibody is known to interfere with the development of active immunity in dogs and additional boosters will be required in most young animals.
All dogs should initially receive one dose of this product and a second dose 2 to 3 weeks later.
Historically, annual revaccination with a single dose has been recommended for this product. The need for this booster has not been established. For advice on revaccination frequency and annual booster vaccinations, consultation with a veterinarian is recommended.
| Directions | Rehydrate with sterile diluent supplied. Shake well. Inject one 0.5 mL dose subcutaneously. Repeat in 2 to 3 weeks. The need for an annual booster vaccination has not been established for this product. Consultation with a veterinarian is recommended. |
|---|
